Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Aug 25, 2016
James Thornton, venture capital investor, discusses Mylan CEO Heather Bresch's explanation for the pricing of the EpiPen. CNBC Contributor Bill George, former CEO of Medtronic, and Darnisha Harrison, Ennaid Therapeutics CEO, weigh in.